You are tasked with analyzing the negative predictive value of an experimental serum marker for ovarian cancer. You choose to enroll 2,000 patients across multiple clinical sites, including both 1,000 patients with ovarian cancer and 1,000 age-matched controls. From the disease and control subgroups, 700 and 100 are found positive for this novel serum marker, respectively. Which of the following represents the NPV for this test?
Q2
Specificity for breast examination is traditionally rather high among community practitioners. A team of new researchers sets forth a goal to increase specificity in detection of breast cancer from the previously reported national average of 74%. Based on the following results, has the team achieved its goal?
Breast cancer screening results:
Patients WITH breast cancer | Patients WITHOUT breast cancer
Test is Positive (+) 21 | 5
Test is Negative (-) 7 | 23
Q3
An inpatient psychiatrist recently had two patients who developed serious gastrointestinal infections while taking clozapine. He was concerned that his patients had developed agranulocytosis, a relatively rare but dangerous adverse event associated with clozapine. When the psychiatrist checked the absolute neutrophil count (ANC) of both patients, one was 450/mm3, while the other was 700/mm3 (N=1,500/mm3). According to the clozapine REMS (Risk Evaluation and Mitigation Strategy) program, severe neutropenia in clozapine recipients has often been defined as an absolute neutrophil count (ANC) less than 500/mm3. Changing the cutoff value to 750/mm3 would affect the test performance of ANC with regard to agranulocytosis in which of the following ways?
Q4
A home drug screening test kit is currently being developed. The cut-off level is initially set at 4 mg/uL, which is associated with a sensitivity of 92% and a specificity of 97%. How might the sensitivity and specificity of the test change if the cut-off level is changed to 2 mg/uL?
Q5
A group of investigators who are studying individuals infected with Trypanosoma cruzi is evaluating the ELISA absorbance cutoff value of serum samples for diagnosis of infection. The previous cutoff point is found to be too high, and the researchers decide to lower the threshold by 15%. Which of the following outcomes is most likely to result from this decision?
Sensitivity/Specificity US Medical PG Practice Questions and MCQs
Question 1: You are tasked with analyzing the negative predictive value of an experimental serum marker for ovarian cancer. You choose to enroll 2,000 patients across multiple clinical sites, including both 1,000 patients with ovarian cancer and 1,000 age-matched controls. From the disease and control subgroups, 700 and 100 are found positive for this novel serum marker, respectively. Which of the following represents the NPV for this test?
A. 700 / (700 + 300)
B. 700 / (300 + 900)
C. 700 / (700 + 100)
D. 900 / (900 + 100)
E. 900 / (900 + 300) (Correct Answer)
Explanation: ***900 / (900 + 300)***
- The **Negative Predictive Value (NPV)** is the probability that a person with a **negative test result** does not have the disease. It is calculated as **true negatives (TN)** divided by the sum of true negatives and **false negatives (FN)**, i.e., TN / (TN + FN).
- In this scenario: there are 1,000 ovarian cancer patients, and 700 tested positive, meaning **300 tested negative (false negatives)**. There are 1,000 controls, and 100 tested positive, meaning **900 tested negative (true negatives)**. Therefore, NPV = 900 / (900 + 300).
*700 / (700 + 300)*
- This calculation represents the sensitivity of the test, which is the proportion of true positives among all individuals with the disease (700 true positives / 1000 diseased individuals).
- It does not account for the true negatives or false positives, which are crucial for determining predictive values.
*700 / (300 + 900)*
- This formula mixes elements and does not correspond to a standard measure of test validity.
- The numerator (700) is the number of true positives, and the denominator incorrectly combines false negatives (300) and true negatives (900).
*700 / (700 + 100)*
- This calculation represents the **Positive Predictive Value (PPV)**, which is the probability that a person with a **positive test result** actually has the disease (700 true positives / (700 true positives + 100 false positives)).
- It does not assess the negative predictive power of the test.
*900 / (900 + 100)*
- This calculation represents the **specificity** of the test, which is the proportion of true negatives among all individuals without the disease (900 true negatives / 1000 controls).
- While this involves true negatives, it does not account for false negatives, which are essential for calculating NPV.
Question 2: Specificity for breast examination is traditionally rather high among community practitioners. A team of new researchers sets forth a goal to increase specificity in detection of breast cancer from the previously reported national average of 74%. Based on the following results, has the team achieved its goal?
Breast cancer screening results:
Patients WITH breast cancer | Patients WITHOUT breast cancer
Test is Positive (+) 21 | 5
Test is Negative (-) 7 | 23
A. No, the research team’s results lead to nearly the same specificity as the previous national average.
B. Yes, the team has achieved an increase in specificity of over 15%.
C. It can not be determined, as the prevalence of breast cancer is not listed.
D. It can not be determined, since the numbers affiliated with the first trial are unknown.
E. Yes, the team has achieved an increase in specificity of approximately 8%. (Correct Answer)
Explanation: ***Yes, the team has achieved an increase in specificity of approximately 8%.***
- Specificity is calculated as **True Negatives / (True Negatives + False Positives)**. In this case, specificity = 23 / (23 + 5) = 23 / 28 = 0.8214 or **82.14%**.
- Comparing this to the national average of 74%, the increase is 82.14% - 74% = **8.14%**.
*No, the research team’s results lead to nearly the same specificity as the previous national average.*
- The calculated specificity is **82.14%**, which is significantly higher than the 74% national average, not nearly the same.
- An **8% increase** represents a substantial improvement in the ability of the test to correctly identify individuals without the disease.
*Yes, the team has achieved an increase in specificity of over 15%.*
- The calculated increase in specificity is **8.14%**, which is less than 15%.
- This option incorrectly overestimates the magnitude of the improvement.
*It can not be determined, as the prevalence of breast cancer is not listed.*
- Prevalence is used to calculate **positive and negative predictive values**, but not sensitivity or specificity.
- Specificity can be directly calculated from the provided data on true negatives and false positives.
*It can not be determined, since the numbers affiliated with the first trial are unknown.*
- To answer the question, we only need the **original national average specificity (74%)** for comparison and the current trial's results to calculate the new specificity.
- The raw numbers from the "first trial" (national average) are not required to determine if the goal was met.
Question 3: An inpatient psychiatrist recently had two patients who developed serious gastrointestinal infections while taking clozapine. He was concerned that his patients had developed agranulocytosis, a relatively rare but dangerous adverse event associated with clozapine. When the psychiatrist checked the absolute neutrophil count (ANC) of both patients, one was 450/mm3, while the other was 700/mm3 (N=1,500/mm3). According to the clozapine REMS (Risk Evaluation and Mitigation Strategy) program, severe neutropenia in clozapine recipients has often been defined as an absolute neutrophil count (ANC) less than 500/mm3. Changing the cutoff value to 750/mm3 would affect the test performance of ANC with regard to agranulocytosis in which of the following ways?
A. Decreased true positives
B. Increased positive predictive value
C. Increased false positives (Correct Answer)
D. Unchanged specificity
E. Decreased sensitivity
Explanation: ***Increased false positives***
- Raising the **ANC cutoff** from 500/mm³ to 750/mm³ means more individuals with an ANC between 500 and 750/mm³ will now be classified as having neutropenia.
- This increases the likelihood of classifying patients without agranulocytosis as having the condition, thereby increasing **false positives**.
*Decreased true positives*
- A higher cutoff would likely lead to an **increase in true positives**, not a decrease, as more cases meeting the criteria for severe neutropenia would be identified.
- It would capture more patients who genuinely have low ANC, even if they don't develop full-blown agranulocytosis.
*Increased positive predictive value*
- An increase in **false positives** would lead to a decrease in **positive predictive value (PPV)**, as a smaller proportion of positive test results would truly represent agranulocytosis.
- PPV is the probability that a positive test result reflects the actual presence of the disease.
*Unchanged specificity*
- **Specificity** is the ability of the test to correctly identify those *without* the disease. By lowering the threshold (making it easier to test positive), specificity would decrease, not remain unchanged.
- Many healthy individuals with ANC between 500-750/mm³ would now be incorrectly classified as having severe neutropenia.
*Decreased sensitivity*
- **Sensitivity** refers to the ability of a test to correctly identify those *with* the disease. By lowering the cutoff (making it easier to test positive for neutropenia), sensitivity would increase, not decrease.
- More true cases of severe neutropenia (and potential agranulocytosis) would be detected earlier.
Question 4: A home drug screening test kit is currently being developed. The cut-off level is initially set at 4 mg/uL, which is associated with a sensitivity of 92% and a specificity of 97%. How might the sensitivity and specificity of the test change if the cut-off level is changed to 2 mg/uL?
A. Sensitivity = 92%, specificity = 97%
B. Sensitivity = 95%, specificity = 98%
C. Sensitivity = 100%, specificity = 97%
D. Sensitivity = 90%, specificity = 99%
E. Sensitivity = 97%, specificity = 96% (Correct Answer)
Explanation: ***Sensitivity = 97%, specificity = 96%***
- Lowering the cut-off from 4 mg/uL to 2 mg/uL means that more individuals will be classified as **positive** (anyone with drug levels ≥2 mg/uL instead of ≥4 mg/uL). This change will **increase the sensitivity** (capturing more true positives, fewer false negatives) but **decrease the specificity** (more false positives among those without the condition).
- Therefore, sensitivity will increase (e.g., to 97%), and specificity will decrease (e.g., to 96%), reflecting the fundamental trade-off between these metrics.
*Sensitivity = 92%, specificity = 97%*
- This option reflects the **original values** at the 4 mg/uL cut-off and does not account for the change in the threshold.
- A change in the cut-off level will inherently alter the test's performance characteristics.
*Sensitivity = 95%, specificity = 98%*
- This option suggests an increase in **both sensitivity and specificity**, which is generally not possible by simply changing the cut-off level in the same direction.
- There is typically an **inverse relationship** between sensitivity and specificity when adjusting the cut-off threshold.
*Sensitivity = 100%, specificity = 97%*
- Reaching **100% sensitivity** while maintaining a high specificity is highly unlikely with a simple cut-off adjustment.
- While sensitivity would increase with a lower cut-off, achieving perfect sensitivity is unrealistic in clinical practice.
*Sensitivity = 90%, specificity = 99%*
- This option suggests a **decrease in sensitivity** and an **increase in specificity**.
- A lower cut-off would lead to more positive results, thus increasing sensitivity and reducing specificity, which contradicts the proposed values.
Question 5: A group of investigators who are studying individuals infected with Trypanosoma cruzi is evaluating the ELISA absorbance cutoff value of serum samples for diagnosis of infection. The previous cutoff point is found to be too high, and the researchers decide to lower the threshold by 15%. Which of the following outcomes is most likely to result from this decision?
A. Increased negative predictive value (Correct Answer)
B. Unchanged true positive results
C. Decreased sensitivity
D. Increased specificity
E. Increased positive predictive value
Explanation: ***Increased negative predictive value***
- Lowering the absorbance cutoff for the ELISA test makes it **easier to test positive**, which increases **sensitivity** (more true positives are detected, fewer false negatives occur).
- **Negative predictive value (NPV)** is the probability that a person who tests negative truly does not have the disease: NPV = TN / (TN + FN).
- When the cutoff is lowered, **fewer infected individuals will be missed** (false negatives decrease). This reduction in false negatives improves the NPV because there are fewer disease-positive individuals in the "test-negative" group.
- Therefore, a negative test result becomes **more reliable at ruling out infection**, increasing the NPV.
*Unchanged true positive results*
- Lowering the cutoff means that samples with lower absorbance values (previously below threshold) from truly infected individuals will now be classified as positive.
- This directly **increases the number of true positive results**, not keeps them unchanged.
- The whole purpose of lowering the threshold is to capture more infected cases.
*Decreased sensitivity*
- **Sensitivity** = TP / (TP + FN), the ability to correctly identify those with disease.
- Lowering the cutoff **increases sensitivity** by making it easier to test positive, thereby capturing more true positives and reducing false negatives.
- A lower threshold would never decrease sensitivity—it does the opposite.
*Increased specificity*
- **Specificity** = TN / (TN + FP), the ability to correctly identify those without disease.
- Lowering the cutoff causes some uninfected individuals to now test positive (false positives increase).
- This **decreases specificity**, not increases it, as fewer true negatives remain.
*Increased positive predictive value*
- **PPV** = TP / (TP + FP), the probability that a positive test indicates true disease.
- While lowering the cutoff increases true positives, it also **increases false positives more substantially**.
- The increased false positives dilute the proportion of true positives among all positive results, thereby **decreasing the PPV**.
